Zealand Pharma A/S | ZEAL - Gross Profit On Sales

Stock Price
346.60
Daily Change
5.40 1.58%
Monthly
20.14%
Yearly
-18.62%
Q2 Forecast
324.96

Zealand Pharma A/S reported 68.91M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Akebia Therapeutics USD 47.28M 1.7M Dec/2025
Alaunos Therapeutics USD -1.13M 1.11M Sep/2024
Avita Medical AUD 14.31M 639K Dec/2025
Dianthus Therapeutics USD 284K 112K Dec/2025
Ionis Pharmaceuticals USD 243M 48M Mar/2026
IQVIA Holdings USD 1.07B 52M Mar/2026
Moderna USD -566M 792M Mar/2026
Organon & Co USD 854M 3M Dec/2025
Revvity USD 387.66M 34M Mar/2026
Tectonic Therapeutic USD 0 0 Mar/2025
Tilray USD 57.47M 10.16M Jun/2025
Viatris USD 1.38B 229.9M Mar/2026
Xeris Pharmaceuticals USD 72.15M 8.77M Dec/2025
Zealand Pharma A/S 68.91M 19.35M Dec/2025